1. 107 Preservation of Normal Concentration of Pituitary Gonadotropins Despite Achievement of Normal Serum Testosterone Levels in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto). (1st February 2018) Authors: Conners, W.; Morgentaler, A.; Guidry, M.; Westfield, G.; Bryson, N.; Goldstein, I. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 301 One-Year Hematologic Safety of Natesto (testosterone) Nasal Gel in Men with Hypogonadism. (1st February 2018) Authors: Guidry, M.; Westfield, G.; Rogol, A.; Bryson, N. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 310 Clinical Improvements in Erectile Function and Mood in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto). (1st February 2018) Authors: Lipshultz, L.; Westfield, G.; Guidry, M.; Bryson, N.; Khera, M. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Natesto™, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. (22nd December 2015) Authors: Rogol, A. D.; Tkachenko, N.; Bryson, N. Journal: Andrology Issue: Volume 4:Number 1(2016:Jan.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗